North America Veterinary Diagnostics Market Forecast to 2030 - Regional Analysis - by Product, Technology, Animal Type, Disease Type, and End User

Description

List of Tables

The North America veterinary diagnostics market was valued at US$ 1,711.65 million in 2022 and is expected to reach US$ 3,138.89 million by 2030; it is estimated to grow at a CAGR of 7.9% from 2022 to 2030.

Growing Ownership of Companion Animals Fuels the North America Veterinary Diagnostics Market

In recent years, increasing disposable income and growing interest of millennials, especially adults in their early 20s and late 30s, for pet adoption are supporting the pet culture across the globe. In addition, due to the onset of the COVID-19 pandemic, people were working from home and self-isolating; this change in lifestyle inspired households to own pets. Since there was no evidence that pets could contribute to the spread of COVID-19, people felt safe with an animal companion that provided mental and emotional support during the pandemic. According to the 2021-2022 National Pet Owners Survey conducted by the American Pet Products Association (APPA), approximately 90.5 million or 70% of the households in the US own one or more pets, the majority being dogs and cats. According to the American Pet Products Association, pet ownership increased from 68% in 2016 to 70% in 2021. More than 67% of American households own almost 400 million pets, including dogs, cats, horses, birds, fish, and more. According to the American Society for the Prevention of Cruelty to Animals, ~6.5 million companion animals enter the countrywide animal shelters annually. According to Euromonitor International, households will continue to exit poverty and reach the middle class and thus, by 2040, 856 million households will have disposable incomes between US$ 15,000 and US$ 45,000, i.e., one in three households worldwide (35.5%). Due to increasing disposable income, companion animal adoption rates are growing. The advancement in the detecting animal diseases and increasing disposable income among pet owners drive the veterinary diagnostics market globally.

North America Veterinary Diagnostics Market Overview

The North America veterinary diagnostics market has been segmented into the US, Canada, and Mexico. The market growth in this region is attributed to the rising infectious animal diseases standing as a standalone factor positively influencing the growth of the market. Additionally, technological advancements in monitoring devices further enhances the overall market growth during 2022-2030. According to the Centers for Disease Control and Prevention (CDC) report, enteric diseases linked to animals are estimated to account for 450,000 illnesses, 5,000 hospitalizations, and 76 deaths in the US alone annually. Bacteria and parasites were the only types of etiologies reported. For example, "Cryptosporidium" was the most common cause of confirmed, single-etiology outbreaks, accounting for 21 outbreaks in the US, followed by Salmonella with 18 (35%) in 2020. In the US, certain veterinary diagnostics are regulated and dependent on the US Department of Agriculture-Center for Veterinary Biologics (USDA-CVB) for approval. These involve veterinary diagnostic kits intended to diagnose pathogens in the animal undergoing treatment. USDA-CVB are point-of-care diagnostics for testing feline leukemia virus (FeLV), canine parvovirus, canine heartworm, and other viruses. Therefore, diagnostic methods are primarily involved in overcoming a high prevalence of animal infections. According to the American Association of Veterinary Laboratory Diagnosticians (AAVLD), at least 500 state and federally funded pathologists and diagnosticians contribute to large animal herd health surveillance in the US and Canada. Also, food animal-focused diagnostic laboratories received over US$ 100 million to perform surveillance for studying a high-impact disease that may affect animal agriculture industries in 2020, as per the data retrieved from Centers for Disease Control and Prevention (CDC). Therefore, early recognition of emerging pathogens can benefit in controlling animal disease infection and identifying potential zoonoses. Thus, the aforementioned factors positively influence the North America veterinary diagnostics market.

North America Veterinary Diagnostics Market Revenue and Forecast to 2030 (US$ Million)

North America Veterinary Diagnostics Market Segmentation

The North America veterinary diagnostics market is segmented based on product, technology, disease type, animal type, end user, and country.

Based on product, the North America veterinary diagnostics market is bifurcated into instruments and consumables. The instruments segment held a larger share in 2022.

By technology, the North America veterinary diagnostics market is segmented into immunodiagnostics, clinical biochemistry, hematology, molecular diagnostics, and other veterinary diagnostic technologies. The immunodiagnostics segment held the largest share in 2022. The immunodiagnostics segment is further subsegmented into lateral flow assays, ELISA, immunoassay, allergen-specific immunodiagnostics test, and other immunodiagnostics. The clinical biochemistry segment is further subsegmented into clinical chemistry analysis, glucose monitoring, and blood gas and electrolyte.

By disease type, the North America veterinary diagnostics market is segmented into infectious diseases and non-infectious disease. The infectious diseases segment held the largest share in 2022.

By animal type, the North America veterinary diagnostics market is bifurcated into livestock animals and companion animals. The companion animals segment held a larger share in 2022. The livestock animals segment is further subsegmented into cattle, pigs, poultry, and other livestock animals. The companion animals segment is further subsegmented into dogs, cats, horses, and other companion animals.

By end user, the North America veterinary diagnostics market is segmented into veterinary hospitals and clinics, animal diagnostic laboratories, and veterinary research institutes and universities. The companion animals segment held the largest share in 2022.

Based on country, the North America veterinary diagnostics market is segmented into the US, Canada, and Mexico. The US dominated the North America veterinary diagnostics market in 2022.

FUJIFILM Holdings Corp, Heska Corp, Idexx Laboratories Inc, INDICAL BIOSCIENCE GmbH, Merck Animal Health, Neogen Corp, Randox Laboratories Ltd, Thermo Fisher Scientific Inc, Virbac SA, and Zoetis Inc are some of the leading companies operating in the North America veterinary diagnostics market.

Product Code: BMIRE00029659

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights
2.2 North America Veterinary Diagnostics Market, by Country (US$ Million)

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Veterinary Diagnostics Market - Key Industry Dynamics

4.1 Key Market Drivers
- 4.1.1 Rising Prevalence of Zoonotic Disease
- 4.1.2 Growing Ownership of Companion Animals
4.2 Key Market Restraints
- 4.2.1 Lack of Skilled Professionals in Veterinary Research
4.3 Key Market Opportunities
- 4.3.1 Technological Advancements in Veterinary Diagnostics
4.4 Future Trends
- 4.4.1 Advent of Precision Medicine in Veterinary Diagnostics

5. Veterinary Diagnostics Market - North America Market Analysis

5.1 North America Veterinary Diagnostics Market Revenue (US$ Mn), 2022 - 2030

6. North America Veterinary Diagnostics Market - Revenue and Forecast to 2030 - by Product

6.1 Overview
6.2 North America Veterinary Diagnostics Market Revenue Share, by Product 2022 & 2030 (%)
6.3 Instruments
- 6.3.1 Overview
- 6.3.2 Instruments: North America Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Consumables
- 6.4.1 Overview
- 6.4.2 Consumables: North America Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

7. North America Veterinary Diagnostics Market - Revenue and Forecast to 2030 - by Technology

7.1 Overview
7.2 North America Veterinary Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
7.3 Immunodiagnostics
- 7.3.1 Overview
- 7.3.2 Immunodiagnostics: North America Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.3 Lateral Flow Assays
  - 7.3.3.1 Lateral Flow Assays: North America Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.4 ELISA Tests
  - 7.3.4.1 ELISA Tests: North America Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.5 Immunoassay Analyzers
  - 7.3.5.1 Immunoassay Analyzers: North America Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.6 Allergen-Specific Immunodiagnostic Tests
  - 7.3.6.1 Allergen-Specific Immunodiagnostic Tests: North America Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.7 Other Immunodiagnostics
  - 7.3.7.1 Other Immunodiagnostics: North America Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Clinical Biochemistry
- 7.4.1 Overview
- 7.4.2 Clinical Biochemistry: North America Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4.3 Clinical Chemistry Analysis
  - 7.4.3.1 Clinical Chemistry Analysis: North America Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4.4 Glucose Monitoring
  - 7.4.4.1 Glucose Monitoring: North America Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4.5 Blood Gas & Electrolyte
  - 7.4.5.1 Blood Gas & Electrolyte: North America Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Hematology
- 7.5.1 Overview
- 7.5.2 Hematology: North America Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Molecular Diagnostics
- 7.6.1 Overview
- 7.6.2 Molecular Diagnostics: North America Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Others Veterinary Diagnostic Technologies
- 7.7.1 Overview
- 7.7.2 Others Veterinary Diagnostic Technologies: North America Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Veterinary Diagnostics Market - Revenue and Forecast to 2030 - by Animal Type

8.1 Overview
8.2 North America Veterinary Diagnostics Market Revenue Share, by Animal Type 2022 & 2030 (%)
8.3 Livestock Animals
- 8.3.1 Overview
- 8.3.2 Livestock Animals: North America Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 8.3.3 Cattle
  - 8.3.3.1 Cattle: North America Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 8.3.4 Pigs
  - 8.3.4.1 Pigs: North America Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 8.3.5 Poultry
  - 8.3.5.1 Poultry: North America Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 8.3.6 Other Livestock Animals
  - 8.3.6.1 Other Livestock Animals: North America Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Companion Animals
- 8.4.1 Overview
- 8.4.2 Companion Animals: North America Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 8.4.3 Dogs
  - 8.4.3.1 Dogs: North America Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 8.4.4 Cats
  - 8.4.4.1 Cats: North America Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 8.4.5 Horses
  - 8.4.5.1 Horses: North America Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
- 8.4.6 Other Companion Animals
  - 8.4.6.1 Other Companion Animals: North America Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Veterinary Diagnostics Market - Revenue and Forecast to 2030 - by Disease Type

9.1 Overview
9.2 North America Veterinary Diagnostics Market Revenue Share, by Disease Type 2022 & 2030 (%)
9.3 Infectious Disease
- 9.3.1 Overview
- 9.3.2 Infectious Disease: North America Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Non-Infectious Disease
- 9.4.1 Overview
- 9.4.2 Non-Infectious Disease: North America Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Veterinary Diagnostics Market - Revenue and Forecast to 2030 - by End User

10.1 Overview
10.2 North America Veterinary Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
10.3 Veterinary Hospitals & Clinics
- 10.3.1 Overview
- 10.3.2 Veterinary Hospitals & Clinics: North America Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Animal Diagnostic Laboratories
- 10.4.1 Overview
- 10.4.2 Animal Diagnostic Laboratories: North America Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Veterinary Research Institutes & Universities
- 10.5.1 Overview
- 10.5.2 Veterinary Research Institutes & Universities: North America Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

11. North America Veterinary Diagnostics Market - Revenue and Forecast to 2030 - Country Analysis

11.1.1 North America: North America Veterinary Diagnostics Market, by Country
- 11.1.1.1 US: North America Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  - 11.1.1.1.1 US: North America Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.1.2 US: North America Veterinary Diagnostics Market, by Product, 2020-2030 (US$ Million)
11.1.3 US: North America Veterinary Diagnostics Market, by Technology, 2020-2030 (US$ Million)
- 11.1.3.1 US: North America Veterinary Diagnostics Market, by Immunodiagnostics, 2020-2030 (US$ Million)
- 11.1.3.2 US: North America Veterinary Diagnostics Market, by Clinical Biochemistry, 2020-2030 (US$ Million)
11.1.4 US: North America Veterinary Diagnostics Market, by Animal Type, 2020-2030 (US$ Million)
- 11.1.4.1 US: North America Veterinary Diagnostics Market, by Livestock Animals, 2020-2030 (US$ Million)
- 11.1.4.2 US: North America Veterinary Diagnostics Market, by Companion Animals, 2020-2030 (US$ Million)
11.1.5 US: North America Veterinary Diagnostics Market, by Disease Type, 2020-2030 (US$ Million)
11.1.6 US: North America Veterinary Diagnostics Market, by End User, 2020-2030 (US$ Million)
- 11.1.6.1 Canada: North America Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  - 11.1.6.1.1 Canada: North America Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.1.7 Canada: North America Veterinary Diagnostics Market, by Product, 2020-2030 (US$ Million)
11.1.8 Canada: North America Veterinary Diagnostics Market, by Technology, 2020-2030 (US$ Million)
- 11.1.8.1 Canada: North America Veterinary Diagnostics Market, by Immunodiagnostics, 2020-2030 (US$ Million)
- 11.1.8.2 Canada: North America Veterinary Diagnostics Market, by Clinical Biochemistry, 2020-2030 (US$ Million)
11.1.9 Canada: North America Veterinary Diagnostics Market, by Animal Type, 2020-2030 (US$ Million)
- 11.1.9.1 Canada: North America Veterinary Diagnostics Market, by Livestock Animals, 2020-2030 (US$ Million)
- 11.1.9.2 Canada: North America Veterinary Diagnostics Market, by Companion Animals, 2020-2030 (US$ Million)
11.1.10 Canada: North America Veterinary Diagnostics Market, by Disease Type, 2020-2030 (US$ Million)
11.1.11 Canada: North America Veterinary Diagnostics Market, by End User, 2020-2030 (US$ Million)
- 11.1.11.1 Mexico: North America Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  - 11.1.11.1.1 Mexico: North America Veterinary Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.1.12 Mexico: North America Veterinary Diagnostics Market, by Product, 2020-2030 (US$ Million)
11.1.13 Mexico: North America Veterinary Diagnostics Market, by Technology, 2020-2030 (US$ Million)
- 11.1.13.1 Mexico: North America Veterinary Diagnostics Market, by Immunodiagnostics, 2020-2030 (US$ Million)
- 11.1.13.2 Mexico: North America Veterinary Diagnostics Market, by Clinical Biochemistry, 2020-2030 (US$ Million)
11.1.14 Mexico: North America Veterinary Diagnostics Market, by Animal Type, 2020-2030 (US$ Million)
- 11.1.14.1 Mexico: North America Veterinary Diagnostics Market, by Livestock Animals, 2020-2030 (US$ Million)
- 11.1.14.2 Mexico: North America Veterinary Diagnostics Market, by Companion Animals, 2020-2030 (US$ Million)
11.1.15 Mexico: North America Veterinary Diagnostics Market, by Disease Type, 2020-2030 (US$ Million)
11.1.16 Mexico: North America Veterinary Diagnostics Market, by End User, 2020-2030 (US$ Million)

12. Industry Landscape

12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
- 12.3.1 Overview
12.4 Inorganic Developments
- 12.4.1 Overview

13. Company Profiles

13.1 Thermo Fisher Scientific Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Idexx Laboratories Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Zoetis Inc
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Heska Corp
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Neogen Corp
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Randox Laboratories Ltd
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Virbac SA
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 INDICAL BIOSCIENCE GmbH
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 FUJIFILM Holdings Corp
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Merck Animal Health
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments

14. Appendix

14.1 About Us
14.2 Glossary of Terms